40 related articles for article (PubMed ID: 22873092)
1. Hypersensitivity reaction to nedaplatin: A case report and literature review.
Gan K; Ma D
Medicine (Baltimore); 2023 Dec; 102(50):e36690. PubMed ID: 38115255
[TBL] [Abstract][Full Text] [Related]
2. Rechallenges without desensitization following platinum-based chemotherapy reactions.
Young FD; Aung S; Tang M; Anstey KM; Lee MC; Alfaro E; Cinar P; Ho H; Otani IM
J Oncol Pharm Pract; 2024 Apr; 30(3):572-575. PubMed ID: 38347725
[TBL] [Abstract][Full Text] [Related]
3. Hypersensitivity to oxaliplatin: clinical features and risk factors.
Parel M; Ranchon F; Nosbaum A; You B; Vantard N; Schwiertz V; Gourc C; Gauthier N; Guedat MG; He S; Kiouris E; Alloux C; Vial T; Trillet-Lenoir V; Freyer G; Berard F; Rioufol C
BMC Pharmacol Toxicol; 2014 Jan; 15():1. PubMed ID: 24417770
[TBL] [Abstract][Full Text] [Related]
4. A survey of carboplatin desensitization therapy in Japan: A multicenter retrospective study.
Komatsu H; Matsumoto K; Morita M; Nagasawa T; Nishio H; Suzuki J; Nishio S; Kobara H; Yunokawa M; Ariyoshi K; Hirayama T; Tokunaga H; Ukita M; Yoriki K; Mori-Uchino M; Furusawa A; Togami S; Nakamura H; Ishikawa M; Satoh T
Cancer Med; 2024 Mar; 13(5):e6968. PubMed ID: 38491829
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of immediate hypersensitivity reaction to paclitaxel-based chemotherapy in gynecologic cancer patients.
Thangwonglers T; Santimaleeworagun W; Therasakvichya S; Saengsukkasemsak N; Pimsi P
Asian Pac J Allergy Immunol; 2023 Dec; 41(4):340-346. PubMed ID: 33068367
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of toxicities related to novel therapy in clinical trials for women with gynecologic cancer.
Lee YC; Wang L; Kohn EC; Rubinstein L; Ivy SP; Harris PJ; Lheureux S
Cancer; 2020 May; 126(10):2139-2145. PubMed ID: 32097505
[TBL] [Abstract][Full Text] [Related]
7. Rates of paclitaxel hypersensitivity reactions using a modified Markman's infusion protocol as primary prophylaxis.
Symons R; Heath F; Duggan J; Bui KT; Byun L; Friedlander M; Lee YC
Support Care Cancer; 2024 Apr; 32(5):292. PubMed ID: 38632132
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis and management of hypersensitivity reactions related to common cancer chemotherapy agents.
Lee C; Gianos M; Klaustermeyer WB
Ann Allergy Asthma Immunol; 2009 Mar; 102(3):179-87; quiz 187-9, 222. PubMed ID: 19354063
[TBL] [Abstract][Full Text] [Related]
9. Oxaliplatin-associated hypersensitivity reactions: clinical presentation and management.
Hewitt MR; Sun W
Clin Colorectal Cancer; 2006 Jul; 6(2):114-7. PubMed ID: 16945166
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy-related hypersensitivity reaction in Japanese patients with gynecologic malignancy.
Kitada K; Hashiguchi Y; Fukuda T; Yoshida H; Ichimura T; Matsumoto Y; Yasui T; Sumi T; Ishiko O
Eur J Gynaecol Oncol; 2012; 33(3):252-4. PubMed ID: 22873092
[TBL] [Abstract][Full Text] [Related]
11. Retreatment with nedaplatin in patients with recurrent gynecological cancer after the development of hypersensitivity reaction to carboplatin.
Arimoto T; Oda K; Nakagawa S; Kawana K; Tsukazaki T; Adachi K; Matsumoto Y; Yano T; Kozuma S; Taketani Y
J Obstet Gynaecol Res; 2013 Jan; 39(1):336-40. PubMed ID: 22690725
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of substituting nedaplatin after carboplatin hypersensitivity reactions in gynecologic malignancies.
Michikami H; Minaguchi T; Ochi H; Onuki M; Okada S; Matsumoto K; Satoh T; Oki A; Yoshikawa H
J Obstet Gynaecol Res; 2013 Jan; 39(1):330-5. PubMed ID: 22640034
[TBL] [Abstract][Full Text] [Related]
13. Hypersensitivity reactions and the utility of oral and intravenous desensitization in patients with gynecologic malignancies.
Robinson JB; Singh D; Bodurka-Bevers DC; Wharton JT; Gershenson DM; Wolf JK
Gynecol Oncol; 2001 Sep; 82(3):550-8. PubMed ID: 11520154
[TBL] [Abstract][Full Text] [Related]
14. Clinical features of hypersensitivity reactions to carboplatin.
Markman M; Kennedy A; Webster K; Elson P; Peterson G; Kulp B; Belinson J
J Clin Oncol; 1999 Apr; 17(4):1141. PubMed ID: 10561172
[TBL] [Abstract][Full Text] [Related]
15. Incidence of and risk factors associated with nedaplatin-related hypersensitivity reactions.
Kawarada Y; Miyazaki M; Itoh A; Araki R; Iwamizu H; Kataoka T; Kumakura Y; Ota A; Nagai T; Yamada K
Int J Clin Oncol; 2017 Jun; 22(3):593-599. PubMed ID: 28124284
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
